Andere talen Scholar Rock Holding Corporation

Aandelen

SRRK

US80706P1030

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,79 ^USD	+5,64%		+5,64%	-21,33%

28/03	Scholar Rock-aandelen stijgen nadat Raymond James de dekking initieert	MT
28/03	SCHOLAR ROCK HOLDING CORPORATION : Raymond James zet aandeel op kooplijst	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	15/04
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	12/04
Scholar Rock Shares Rise After Raymond James Initiates Coverage	28/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress	19/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
North American Morning Briefing : Investors -2-	18/03
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/03
North American Morning Briefing : Stock Futures -2-	11/03
Scholar Rock : Corporate Presentation March 2024	05/03
Scholar Rock to Participate in Upcoming Investor Conferences	28/02
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16/02
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer	15/02
Scholar Rock Announces Management Appointments	15/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia	25/01
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab	23/01
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Scholar Rock Holding Corporation

Aandelen

SRRK

US80706P1030

Andere talen

Filters